A Study of Safety and Immune Response to Different Doses of a Cytomegalovirus Vaccine in Healthy Adults

Clinical trial NCT05089630 · COMPLETED

Trial details

NCT number: NCT05089630
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Cytomegalovirus Infections

Start date: 2021-10-14
Primary completion: 2025-04-02
Enrollment: 333

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.